المؤلفون: Petros Christopoulos, Franziska Herster, Petra Hoffknecht, Markus Falk, Markus Tiemann, Hans-Georg Kopp, Andre Althoff, Anja Stammberger, Eckart Laack

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: EGFR, non-small cell lung cancer (NSCLC), afatinib, uncommon mutation, tyrosine kinase inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2024.1347742/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/d9d647cfc3ce49f18e8635c29acf8bc3Test

المؤلفون: Frank Griesinger, MD, PhD, Wilfried E.E. Eberhardt, MD, PhD, Wolfgang M. Brueckl, MD, PhD, Horst-Dieter Hummel, MD, PhD, Bastian Jaeschke, MD, Jens Kern, MD, Claas Wesseler, MD, Martina Jänicke, PdD, Annette Fleitz, PhD, Stefan Zacharias, PhD, Annette Hipper, PhD, Annika Groth, MD, PhD, Wilko Weichert, MD, PhD, Steffen Dörfel, Volker Petersen, MD, Jan Schröder, MD, Jochen Wilke, MD, Martin Sebastian, MD, Michael Thomas, MD, PhD, Juliana Ababei, Jürgen Alt, Andreas Ammon, Jürgen Anhuf, Ivo Azeh, Stefan Bauer, Dirk Behringer, Winfried Berger, Christiane Bernhardt, Mathias Bertram, Michael Boesche, Sabine Bohnet, Harald-Robert Bruch, Wolfgang Brückl, Ulrike Burkhard-Meier, Petros Christopoulos, Klaus-Ulrich Däßler, Maike de Wit, Tobias Dechow, Reinhard Depenbusch, Lutz Dietze, Markus Dommach, Wilfried Eberhardt, Corinna Elender, Wolfgang Elsel, Till-Oliver Emde, Martin Faehling, Thomas Fietz, Jürgen R. Fischer, Dimitri Flieger, Anke Freidt, Werner Freier, Christian Frenzel, Florian Fuchs, Roswitha Fuchs, Tobias Gaska, Wolfgang Gleiber, Christian Grah, Frank Griesinger, Christian Grohé, Matthias Groschek, Björn Güldenzoph, Andreas Günther, Siegfried Haas, Matthias Hackenthal, Volker Hagen, Lars Hahn, Verena Hannig Carla, Richard Hansen, Hanns-Detlev Harich, Monika Heilmann, Kathrin Heinrich, Christiane Hering-Schubert, Jörg Heßling, Petra Hoffknecht, Patricia Hortig, Gerdt Hübner, Horst-Dieter Hummel, Ulrich Hutzschenreuter, Thomas Illmer, Georg Innig, Bastian Jaeschke, Christian Junghanß, Ulrich Kaiser, Haytham Kamal, Kato Kambartel, Jens Kern, Martin Kimmich, Dorothea Kingreen, Heinz Kirchen, Martine Klausmann, Ortwin Klein, Konrad Kokowski, Wolfgang Körber, Cornelius Kortsik, Dirk Koschel, Benoit Krämer, Beate Krammer-Steiner, Eckart Laack, Christof Lamberti, Rumo David Leistner, Christoph Losem, Andreas Lück, Christoph Maintz, Kerstin Martin, Dirk Medgenberg, Martin Metzenmacher, Christian Meyer zum Büschenfelde, Philipp Meyn, Enno Moorahrend, Annette Müller, Lothar Müller, Michael Neise, Holger Nückel, Arnd Nusch, Tobias Overbeck, Henning Pelz, Volker Petersen, Bettina Peuser, Margarete Plath, Winfried J. Randerath, Jacqueline Rauh, Martin Reck, Dietmar Reichert, Niels Reinmuth, Marcel Reiser, Roland Repp, Daniel Reschke, Achim Rittmeyer, Yolanda Rodemer, Sandra Sackmann, Parvis Sadjadian, Reiner Sandner, Annette Sauer, Harald Schäfer, Christoph Schaudt, Rudolf Schlag, Burkhard Schmidt, Stephan Schmitz, Jan Schröder, Michael Schroeder, Mathias Schulze, Christian Schumann, Wolfgang Schütte, Martin Schwaiblmair, Florian Schwindt Peter, Martin Sebastian, Bernd Seese, Gernot Seipelt, Thomas Sorgenfrei, Johannes Steiff, Heike Steiniger, Tanja Trarbach, Amanda Tufman, Jens Uhlig, Ursula Vehling-Kaiser, Eyck von der Heyde, Ulla von Verschuer, Cornelius Waller, Thomas Wehler, Georg Weißenborn, Florian Weißinger, Martin Wermke, Claas Wesseler, Jörg Wiegand, Stefan Wilhelm, Jochen Wilke, Mark-Oliver Zahn, Matthias Zaiss, Matthias Zeth

المصدر: JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100626- (2024)

مصطلحات موضوعية: Non–small cell lung carcinoma, Prospective studies, Immune checkpoint inhibitors, Pembrolizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364323001698Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/193c505adea04fdda590997c6e7e69c0Test

المؤلفون: Balázs Jóri, Christine Vössing, Judith Pirngruber, Eva Maria Willing, Kathrin Arndt, Markus Falk, Markus Tiemann, Lukas C. Heukamp, Petra Hoffknecht

المصدر: Current Oncology, Vol 30, Iss 10, Pp 8805-8814 (2023)

مصطلحات موضوعية: osimertinib, crizotinib, cabozantinib, sequential therapy, resistance, c-MET, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1718-7729/30/10/635Test; https://doaj.org/toc/1198-0052Test; https://doaj.org/toc/1718-7729Test

الوصول الحر: https://doaj.org/article/4e628e918b044546be96ca670e533995Test

المؤلفون: Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt, Christoph Szuszies, Albrecht Neesse, Petra Hoffknecht, Cyrus Khandanpour, Jan-Henrik Mikesch, Matthias Stelljes, Göran Ramin Boeckel, Phil-Robin Tepasse, Lea Reitnauer, Raphael Koch, Justin Hasenkamp, Ulrike Bacher, Simone Scheithauer, Lorenz Trümper, Norbert Schmitz, Gerald Wulf, Andrea Kerkhoff, Georg Lenz, Carolin Krekeler, Annalen Bleckmann

المصدر: Cancers, Vol 14, Iss 15, p 3746 (2022)

مصطلحات موضوعية: SARS-CoV-2, COVID-19, COVID-19 vaccination, cancer patients, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/14/15/3746Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/52432a54743542dc8634583697fa4c95Test

المؤلفون: Martin Faehling, Christian Schumann, Petros Christopoulos, Petra Hoffknecht, Jürgen Alt, Marlitt Horn, Stephan Eisenmann, Anke Schlenska-Lange, Philipp Schütt, Felix Steger, Wolfgang M. Brückl, Daniel C. Christoph

المصدر: Data in Brief, Vol 34, Iss , Pp 106556- (2021)

مصطلحات موضوعية: NSCLC, PD-L1, Checkpoint inhibitor, Survival, Real world, Oligometastatic, Computer applications to medicine. Medical informatics, R858-859.7, Science (General), Q1-390

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352340920314384Test; https://doaj.org/toc/2352-3409Test

الوصول الحر: https://doaj.org/article/05cec1d0dcbe40d8bb40153fc5d15af0Test

المؤلفون: Wolfgang M Brueckl, Martin Reck, Achim Rittmeyer, Jens Kollmeier, Claas Wesseler, Gunther H Wiest, Petros Christopoulos, Amanda Tufman, Petra Hoffknecht, Bernhard Ulm, Fabian Reich, Joachim H Ficker, Eckart Laack

المصدر: Clinical Medicine Insights: Oncology, Vol 14 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1179-5549Test

الوصول الحر: https://doaj.org/article/cfc495dfbcf041fc93f8a04d10f6baa9Test

المؤلفون: Balázs Jóri, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O. Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger, Markus Tiemann, Lukas C. Heukamp, Markus Falk

المصدر: Cancers, Vol 13, Iss 12, p 2861 (2021)

مصطلحات موضوعية: liquid biopsy, lung cancer, routine diagnostics, osimertinib resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/13/12/2861Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/1d706ef433cc4f37819d862bfaf7c933Test

المؤلفون: Evgenii Shumilov, Petra Hoffknecht, Raphael Koch, Rudolf Peceny, Steffen Voigt, Nicole Schmidt, Micha Peeck, Ulrike Bacher, Simone Scheithauer, Lorenz Trümper, Georg Lenz, Andrea Kerkhoff, Annalen Bleckmann

المصدر: Cancers, Vol 13, Iss 12, p 2917 (2021)

مصطلحات موضوعية: SARS-CoV-2, COVID-19, cancer patients, SARS-CoV-2 scenarios, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/13/12/2917Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/37c9f5805385473b97a428b088148455Test

المؤلفون: Stefanie Schatz, Markus Falk, Balázs Jóri, Hayat O. Ramdani, Stefanie Schmidt, Eva-Maria Willing, Roopika Menon, Harry J. M. Groen, Linda Diehl, Matthias Kröger, Claas Wesseler, Frank Griesinger, Petra Hoffknecht, Markus Tiemann, Lukas C. Heukamp

المصدر: Cancers, Vol 12, Iss 6, p 1685 (2020)

مصطلحات موضوعية: immuno-oncology, tumor mutational burden, lung cancer, routine diagnostics, driver mutation, PD-L1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/12/6/1685Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/7a4f925dc71b4832a327e67fb9075603Test

المؤلفون: Petros Christopoulos, Franziska Herster, Petra Hoffknecht, Markus Falk, Markus Tiemann, Hans-Georg Kopp, Andre Althoff, Anja Stammberger, Eckart Laack

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, EGFR, non-small cell lung cancer (NSCLC), afatinib, uncommon mutation, tyrosine kinase inhibitor

العلاقة: https://figshare.com/articles/dataset/DataSheet_1_Activity_of_afatinib_in_patients_with_NSCLC_harboring_novel_uncommon_EGFR_mutations_with_or_without_co-mutations_a_case_report_docx/25756509Test

الإتاحة: https://doi.org/10.3389/fonc.2024.1347742.s001Test
https://figshare.com/articles/dataset/DataSheet_1_Activity_of_afatinib_in_patients_with_NSCLC_harboring_novel_uncommon_EGFR_mutations_with_or_without_co-mutations_a_case_report_docx/25756509Test